Optical Coherence Tomography Technology Market Analysis Report

2013-05-21
Published : May-2013

This report explores present and future different optical coherence tomography techniques and their usage and developments within the OCT market. This report includes different types of optical coherence tomography techniques such as time domain and large-field high-speed polarization sensitive system, Fourier domain or spectral domain and time-encoded frequency domain or swept source, full-field optical coherence and optical delay scanning.  The improvisation of the market, the setbacks and the needs of the market are discussed in this report. The classification, new developments and usage of these types of techniques are also portrayed in this report. A detailed analysis of the OCT (optical coherence tomography) industry has been conducted. Revenues are broken down by region. Sales figures are estimated for the five-year period from 2012 through 2017.

Applications for OCT are also discussed in this report, with an emphasis of the usage of this technique in different therapeutic categories and various other industries. This report, “Global Markets and Technologies for Optical Coherence Tomography (OCT)“,  also covers significant patents and their allotments in each category. Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type/ technology in light of the new technologies, growing competition and changing customer needs.

 

                                                        Request Sample

 

Extensive research in the OCT field has revealed its current usage in various applications and its usage in the future. The report also covers current research and developments going on in this field. This report also discusses the usage of OCT techniques over other current imaging techniques such as magnetic resonance imaging and ultrasound imaging.

Researchers are exploring the advantages of OCT in newer areas, leading to the increased usage and consumption of these techniques. R&D spending, patents and research in this field are giving a new direction. The advancements, new product launches and the early disease detection awareness influenced the market to grow in the foreseeable future. This study looks at almost all of the systems affected by these factors.

Scope of the Report (http://www.reportsnreports.com/reports/247348-global-markets-and-technologies-for-optical-coherence-tomography-oct-.html) covers:

The scope of this study embraces OCT in medical and other markets. BCC analyzed each market and its applications, regulatory environment, technology, market projections and market shares. Technological issues include the latest trends and developments. The emerging markets for OCT include countries such as India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, etc.

Companies Profiled in this report include: Agfa Healthcare, Agiltron Incorporated, Bayspec, Inc., Bioptigen, Carl Zeiss Meditec, Heidelberg Engineering, Heliotis Ag, Imalux Corporation, Lightlab Imaging, Michelson Diagnostics, Nidek Co., Ltd., Novacam Technologies Inc., Nine Point Medical, Optos, Optovue, Inc., Optopol Technology S.A., Phoenix Research Laboratories, Inc., P&P Optica, Santec Corporation, Shenzhen Moptim Imaging Technique Co., Tomey, Tomophase Corporation, Topcon Medical Systems, Inc., Tornado Spectral Systems and Thorlabs Inc.

List of Tables

Summary Table : Global Revenue of Oct Market, Through 2017
Table 1 : Main Characteristics of Oct
Table 2 : Uses of Optical Coherence Tomography
Table 3 : Advantages and Disadvantages of Optical Coherence Tomography
Table 4 : Applications of Optical Coherence Tomography
Table 5 : Historical Developments In Optical Coherence Tomography
Table 6 : Type of Technologies Used In Optical Coherence Tomography
Table 7 : Modes of Implementation In Optical Coherence Tomography
Table 8 : Comparison of Different Oct Technology
Table 9 : New Oct Products Approved From 2008 To 2012
Table 10 : Recalls and Safety Alerts From 2008 To 2012
Table 11 : New Oct Innovations From 2008 To 2012
Table 12 : Pipeline Products for the Oct Market
Table 13 : Global Revenue of Oct By Type, Through 2017
Table 14 : Market Shares of Oct By Type, 2011
Table 15 : Global Revenue of Oct By Region, Through 2017
Table 16 : Global Market Share of Oct By Region, 2011
Table 17 : Global Revenue of Td-Oct and Ps-Oct By Region, Through 2017
Table 18 : Market Share of Global Revenue of Td-Oct and Ps-Oct By Region, 2011
Table 19 : Global Revenue of Fd-Oct and Time-Encoded Oct By Region, Through 2017
Table 20 : Market Share of Fd-Oct and Time-Encoded Oct By Region, 2011
Table 21 : Global Revenue of Ff-Oct and Od-Oct By Region, Through 2017
Table 22 : Market Share of Ff-Oct and Od-Oct By Region, 2011
Table 23 : Global Market of Oct By End Users, Through 2017
Table 24 : Global Market Share of Oct By End Users, 2011
Table 25 : Global Revenue of Td-Oct and Ps-Oct, Through 2017
Table 26 : Market Share of Td-Oct and Ps-Oct By Type, 2011
Table 27 : Global Revenue of Td-Oct By Region, Through 2017
Table 28 : Global Revenue of Ps-Oct By Region, Through 2017
Table 29 : Market Share of Ps-Oct By Region, 2011
Table 30 : Global Revenue of Ps-Oct and Td-Oct By End Users, Through 2017
Table 31 : Global Expenditure of Td-Oct and Ps-Oct In the Pharmaceutical and Biotechnology Industries, Through 2017
Table 32 : Global Expenditure of Td-Oct and Ps-Oct In the Environmental Sciences Industry, Through 2017
Table 33 : Global Expenditure of Td-Oct and Ps-Oct In the Food and Beverage Industry, Through 2017
Table 34 : Global Expenditure of Td-Oct and Ps-Oct In Other Industries, Through 2017
Table 35 : Market Share of Td-Oct and Ps-Oct By Application, 2011
Table 36 : Major Manufacturers In Td-Oct, 2011
Table 37 : Market Share for Manufacturers In Td-Oct, 2011
Table 38 : Major Manufacturers In Ps-Oct, 2011
Table 39 : Market Share for the Manufacturers In Ps-Oct, 2011
Table 40 : Global Revenue of Fd-Oct and Time-Encoded Oct By Type, Through 2017
Table 41 : Market Share of Fd-Oct and Time-Encoded Oct, 2011
Table 42 : Global Revenue of Fd-Oct and Time-Encoded Oct By Region, Through 2017
Table 43 : Global Revenue of Fd-Oct By Region, Through 2017
Table 44 : Global Revenue of Time-Encoded Oct By Region, Through 2017
Table 45 : Market Shares of Fd-Oct and Time-Encoded Oct By Region, 2011
Table 46 : Global Revenue of Fd-Oct and Time-Encoded Oct By End Users, Through 2017
Table 47 : Global Revenue of Fd-Oct and Time-Encoded Domain Oct In Cardiology, Through 2017
Table 48 : Global Revenue of Fd-Oct and Time-Encoded Oct In Ophthalmology, Through 2017
Table 49 : Global Revenue of Fd-Oct and Time-Encoded Oct In Oncology, Through 2017
Table 50 : Global Revenue of Fd-Oct and Time-Encoded Oct In Other Sectors, Through 2017
Table 51 : Market Share of Fd-Oct and Time-Encoded Oct, 2011
Table 52 : Major Manufacturers In Fourier Or Spectral Domain Oct, 2011
Table 53 : Market Share of the Manufacturers In Fourier Or Spectral Domain Oct, 2011
Table 54 : Major Manufacturers In Time-Encoded Oct Or Ss-Oct, 2011
Table 55 : Market Share of the Manufacturers of Time-Encoded Oct Or Ss-Oct, 2011
Table 56 : Global Revenue of Ff-Oct and Od-Oct, Through 2017
Table 57 : Market Share of Ff-Oct and Od-Oct By Type, 2011
Table 58 : Global Revenue of Ff-Oct and Od-Oct By Region, Through 2017
Table 59 : Global Revenue of Ff-Oct By Region, Through 2017
Table 60 : Global Revenue of Od-Oct By Region, Through 2017
Table 61 : Market Share of Ff-Oct and Od-Oct By Region, 2011
Table 62 : Global Revenue of Ff-Oct and Od-Oct By End Users, Through 2017
Table 63 : Global Revenue of Ff-Oct and Od-Oct In Endoscopy, Through 2017
Table 64 : Global Revenue of Ff-Oct and Od-Oct In Oncology, Through 2017
Table 65 : Global Expenditure of Ff-Oct and Od-Oct In Interstitial Cell Studies, Through 2017
Table 66 : Global Expenditure of Ff-Oct and Od-Oct In Other Categories, Through 2017
Table 67 : Market Share of Ff-Oct and Od-Oct By End Users, 2011
Table 68 : Major Manufacturers In Ff-Oct, 2011
Table 69 : Market Share for Manufacturers In Ff-Oct, 2011
Table 70 : Major Manufacturers In Od-Oct, 2011
Table 71 : Market Share for Manufacturers In Od-Oct, 2011
Table 72 : Number of U.S. Patents By Year, From 2008 To 2012
Table 73 : Number of U.S. Patents By Type, From 2008-2012
Table 74 : Number of U.S. Patents By Company, From 2008–October 2012
Table 75 : Number of U.S. Patents By Country, From 2008-2012
Table 76 : Number of U.S. Patents By Assignee, From 2008-2012

List of Figures

Summary Figure : Global Revenue of Oct Market, 2010-2017
Figure 1 : Global Revenue of Oct By Type, 2010-2017
Figure 2 : Market Shares of Oct By Type, 2011
Figure 3 : Global Revenue of Oct By Region, 2010-2017
Figure 4 : Global Market Share of Oct By Region, 2011
Figure 5 : Global Revenue of Td-Oct and Ps-Oct By Region, 2010-2017
Figure 6 : Market Share of Global Revenue of Td-Oct and Ps-Oct By Region, 2011
Figure 7 : Global Revenue of Fd-Oct and Time-Encoded Oct By Region, 2010-2017
Figure 8 : Market Share of Fd-Oct and Time-Encoded Oct By Region, 2011
Figure 9 : Global Revenue of Ff-Oct and Od-Oct By Region, 2010-2017
Figure 10 : Market Share of Ff-Oct and Od-Oct By Region, 2011
Figure 11 : Global Market of Oct By End Users, 2010-2017
Figure 12 : Global Market Share of Oct By End Users, 2011
Figure 13 : Global Revenue of Td-Oct and Ps-Oct, 2010-2017
Figure 14 : Market Share of Td-Oct and Ps-Oct By Type, 2011
Figure 15 : Global Revenue of Td-Oct By Region, 2010-2017
Figure 16 : Global Revenue of Ps-Oct By Region, 2010-2017
Figure 17 : Market Share of Ps-Oct By Region, 2011
Figure 18 : Global Revenue of Ps-Oct and Td-Oct By End Users, 2010-2017
Figure 19 : Global Expenditure of Td-Oct and Ps-Oct In the Pharmaceutical and Biotechnology Industries, 2010-2017
Figure 20 : Global Expenditure of Td-Oct and Ps-Oct In the Environmental Sciences Industry, 2010-2017
Figure 21 : Global Expenditure of Td-Oct and Ps-Oct In the Food and Beverage Industry, 2010-2017
Figure 22 : Global Expenditure of Td-Oct and Ps-Oct In Other Industries, 2010-2017
Figure 23 : Market Share of Td-Oct and Ps-Oct By Application, 2011
Figure 24 : Market Share for Manufacturers In Td-Oct, 2011
Figure 25 : Market Share for the Manufacturers In Ps-Oct, 2011
Figure 26 : Global Revenue of Fd-Oct and Time-Encoded Oct By Type, 2010-2017
Figure 27 : Market Share of Fd-Oct and Time-Encoded Oct, 2011
Figure 28 : Global Revenue of Fd-Oct and Time-Encoded Oct By Region, 2010-2017
Figure 29 : Global Revenue of Fd-Oct By Region, 2010-2017
Figure 30 : Global Revenue of Time-Encoded Oct By Region, 2010-2017
Figure 31 : Market Shares of Fd-Oct and Time-Encoded Oct By Region, 2011
Figure 32 : Global Revenue of Fd-Oct and Time-Encoded Oct By End Users, 2010-2017
Figure 33 : Global Revenue of Fd-Oct and Time-Encoded Domain Oct In Cardiology, 2010-2017
Figure 34 : Global Revenue of Fd-Oct and Time-Encoded Oct In Ophthalmology, 2010-2017
Figure 35 : Global Revenue of Fd-Oct and Time-Encoded Oct In Oncology, 2010-2017
Figure 36 : Global Revenue of Fd-Oct and Time-Encoded Oct In Other Sectors, 2010-2017
Figure 37 : Market Share of Fd-Oct and Time-Encoded Oct, 2011
Figure 38 : Market Share of the Manufacturers In Fourier Or Spectral Domain Oct, 2011
Figure 39 : Market Share of the Manufacturers of Time-Encoded Oct Or Ss-Oct, 2011
Figure 40 : Global Revenue of Ff-Oct and Od-Oct, 2010–2017
Figure 41 : Market Share of Ff-Oct and Od-Oct By Type, 2011
Figure 42 : Global Revenue of Ff-Oct and Od-Oct By Region, 2010-2017
Figure 43 : Global Revenue of Ff-Oct By Region, Through 2017
Figure 44 : Global Revenue of Od-Oct By Region, 2010-2017
Figure 45 : Market Share of Ff-Oct and Od-Oct By Region, 2011
Figure 46 : Global Revenue of Ff-Oct and Od-Oct By End Users, 2010-2017
Figure 47 : Global Revenue of Ff-Oct and Od-Oct In Endoscopy, 2010-2017
Figure 48 : Global Review of Ff-Oct and Od-Oct In Oncology, 2010-2017
Figure 49 : Global Expenditure of Ff-Oct and Od-Oct In Interstitial Cell Studies, 2010-2017
Figure 50 : Global Expenditure of Ff-Oct and Od-Oct In Other Categories, 2010-2017
Figure 51 : Market Share of Ff-Oct and Od-Oct By End Users, 2011
Figure 52 : Market Share for Manufacturers In Ff-Oct, 2011
Figure 53 : Market Share for Manufacturers In Od-Oct, 2011
Figure 54 : Number of U.S. Patents By Year, From 2008 To 2012
Figure 55 : Number of U.S. Patents By Type, From 2008–2012
Figure 56 : Number of U.S. Patents By Assignee, From 2008–2012

Contact [email protected] for further information.

Filed in: Pharmaceuticals and Healthcare
Tags: 
More Reports
Title Price Buy Now

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

“The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......
 $4950

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases,  growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders,  rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on  product in 2021.” Based on products, the topical drug delivery the market is segmented into ......
 $4950

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

“Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......
 $4950

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027

The global Healthcare cloud computing market is projected to reach USD 89.4  billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......
 $4950

Digital Pathology Market by Product (ArtificiaI Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals) – Global Forecast to 2026

“The Digital Pathology market is projected to grow at a CAGR of 13.2% during the forecast period (2021–2026).” The global digital pathology market is projected to reach USD 1,371 million by 2026 from USD 736 million in 2021, at a CAGR of 13.2% during the forecast period. The growth in the digital pathology market is mainly driven by factors such as the increasing adoption of digital pathology to enhance lab efficiency, rising incidence of cancer, and growing applications of digital pathology in drug development and companion diagnostics. On the other hand, the high costs of digital pathology systems are expected to restrain market growth to a certain extent. “The scanners segment accounted for the largest share of the Digital Pathology market in 2020.” Based on products,......
 $4950

Telehealth & Telemedicine Market by Component (Software & Services (RPM, Real-Time), Hardware (Monitors)), Delivery (On-Premise, Cloud-Based), Application (Teleradiology, Telestroke, TeleICU), End User (Provider, Payer) & Region – Global Forecasts to 2027

“The telehealth & telemedicine market is projected to grow at a CAGR of 26.6% during the forecast period (2022–2027).” The global telehealth & telemedicine market is expected to grow at a CAGR of 26.6% during the forecast period, to reach USD 285.7 billion by 2027 from an estimated USD 87.8 billion in 2022.The key factors driving the growth of this market include the need to expand healthcare access, the growing prevalence of chronic diseases and conditions, a shortage of physicians, advancements in telecommunications, government support and raising awareness, and rising technology adoption in the wake of COVID-19. However, regional variations in regulations, fraud, and the use of social media for care providers will restrict the market growth during the forecast period. ......
 $4950

Teleradiology Market by Product & Service (Services, Hardware, Software (PACS, RIS)), Imaging Technique (MRI, CT, X-ray, Ultrasound, Mammography, Nuclear Imaging), End User (Hospitals, Diagnostic Centers& Laboratories), COVID-19 Impact – Forecast to 2026

“A shortage of skilled radiologists & need for faster and improved diagnosis are driving market growth” The teleradiology market is expected to reach USD 14.8billion by 2026 from USD 7.3 billion in 2021, at a CAGR of 15.3% during the forecast period of 2021 to 2026. Due to the outbreak of coronavirus globally, there is a sudden rise in the demand for teleradiology services. The growth of this market is mainly attributed to the growth of the teleradiology market is driven by the rising geriatric population and the subsequent increase in the prevalence of associated diseases; the increasing number of advanced imaging procedures and a shortage of skilled radiologists; advancements in teleradiology the increasing adoption of cloud-based solutions. However, declining reimbursements a......
 $4950

Healthcare Consulting Services Market by Type of Service (Digital Health, IT, Operations, Strategy, Financial, HR & Talent), End User (Government Bodies, Healthcare Providers, Pharmaceutical & Biotechnology Companies), and Region – Global Forecasts to 2026

Global healthcare consulting services market is projected to grow at CAGR of 11.5%” The global healthcare consulting services market is projected to reach USD 41.2 billion by 2026 from USD 23.9 billion in 2021, at a CAGR of 11.5% during the forecast period. Healthcare consulting firms specialize in providing business consulting services to the healthcare industry in areas such as finance, accounting, marketing, insurance, healthcare management, billing, coding, regulations & compliance, healthcare standards, and many other similar areas. Growth in the healthcare consulting services market can be primarily attributed to the growing budget cuts, increasing pricing pressure, changing healthcare policies/regulations, and rising technological disruption across the healthcare industry t......
 $4950

Animal Growth Promoters and Performance Enhancers Market by Type (Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probiotics & Prebiotics, Phytogenic)), Animal Type (Poultry, Porcine, Livestock, Aquaculture) – Global Forecast to 2026

“The global animal growth promoters and performance enhancers market is projected to grow at a CAGR of 5.7%” The global animal growth promoters and performance enhancers market is projected to reach USD 21.4 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 5.7%. Animal health products, including growth promoters and performance enhancers, are types of drugs and chemicals used for animal growth. These enhancers help to digest food more effectively and enable animals to grow faster, which, in turn, help to improve productivity. Growth in the animal growth promoters and performance enhancers market is majorly driven by the rising demand for animal consumption and consumption of livestock-based products, rising global demand for naturally produced growth promoters, and rising......
 $4950

Hemophilia A and B – Epidemiology Forecast to 2030

Hemophilia A and B - Epidemiology Forecast to 2030 Summary Hemophilia is an X-linked hereditary bleeding disorder characterized by impaired blood coagulation because of deficiencies in the production or function of coagulation factor VIII in hemophilia A or factor IX in hemophilia B (Bolton-Maggs and Pasi, 2003). Because of the deficiency of coagulation factor, hemophilia patients have a tendency to bleed in joints, muscles, soft tissues, and within mucous membranes, which can be either spontaneous or due to internal or external trauma, depending on the severity of the disease (CDC, 2021; Mayo Clinic, 2021). According to the World Federation of Hemophilia (WFH), hemophilia is rare. About 1 in 10,000 people are born with hemophilia A and about 1 in 50,000 people are born with hemophilia B......
 $3995
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy